
Perioperative Cardiac Hemodynamics Analysis for Anesthesia Management
Analyze perioperative hemodynamics and optimize cardiac anesthesia pharmacology
What You Can Do
You can rapidly synthesize invasive hemodynamic monitoring, echocardiography, and lab data into coherent clinical assessments that guide inotrope and vasopressor selection specific to cardiac pathology. The skill helps you differentiate between pump dysfunction, volume status, and vasomotor tone problems to anticipate hemodynamic challenges at critical surgical transitions—from pre-bypass optimization through post-bypass weaning—and generate evidence-based pharmacologic reasoning suitable for documentation and peer review.
Features
synthesize MAP, CVP, PA catheter values, TEE findings, lactate, and ScvO2 into unified hemodynamic assessment
tailored strategies for pre-bypass, on-bypass, and post-bypass hemodynamic management
evidence-based drug choice rationales linked to underlying cardiac pathology and hemodynamic phenotype
systematic approach to post-bypass weaning difficulties and acute RV dysfunction
vasopressor selection in context of graft patency and myocardial protection
address comorbidities (renal dysfunction, chronic hypertension, diabetes) affecting hemodynamic strategy
structured pharmacologic reasoning suitable for institutional protocols and peer review
Example Output
Example 1: Post-Bypass Weaning Assessment
Input: Patient post-CABG with MAP 65 mmHg, CVP 8, PAD 18, mixed venous O2 sat 55%, lactate 3.2, TEE shows preserved LV function, dilated RV with reduced contractility.
Output: Hemodynamic phenotype: Low-output state with RV dysfunction and elevated afterload. Recommended intervention: Initiate inhaled pulmonary vasodilator (inhaled nitric oxide or epoprostenol) to reduce RV afterload + moderate-dose inotrope (milrinone 0.5 mcg/kg/min) for inotropy + lusitropic effect on dilated RV. Avoid pure vasoconstrictors that worsen RV dysfunction. Re-assess separation criteria after 15-minute optimization window.
Example 2: Inotrope Selection Rationale
Input: Pre-bypass: MAP 78, CI 2.1 L/min/m², SVR 1200, SvO2 65%, ejection fraction 35%, chronic hypertension on home beta-blocker.
Output: Select dobutamine 5 mcg/kg/min (inotropy + mild afterload reduction for hypertensive patient with depressed contractility) OR low-dose epinephrine if hypotension develops. Avoid pure vasopressors (phenylephrine) that increase afterload in context of LV dysfunction and baseline hypertension.
What's Included
- SKILL.md instruction file: complete anesthesia-specific hemodynamic assessment framework
- Perioperative data synthesis template: structured format for integrating invasive lines, echocardiography, and lab values
- Inotrope/vasopressor selection matrix: drug choice rationales mapped to hemodynamic phenotypes and surgical phases
- Low cardiac output syndrome (LCOS) decision tree: systematic evaluation and management pathway for post-bypass weaning challenges
- Case documentation checklist: evidence-based pharmacologic reasoning structure for quality improvement and peer review
Who It's For
- Anesthesiologists managing complex cardiac surgical cases and hemodynamic optimization
- Certified Registered Nurse Anesthetists (CRNAs) in cardiac operating rooms requiring standardized hemodynamic decision-making
- Cardiac anesthesia fellowship trainees learning systematic inotrope/vasopressor selection
- Perioperative care teams implementing institutional cardiac anesthesia protocols
- Quality improvement committees standardizing low cardiac output syndrome management
Best For
- Pre-bypass hemodynamic optimization and inotrope selection
- Post-bypass weaning assessment and low cardiac output syndrome (LCOS) management
- Acute right ventricular dysfunction or pulmonary hypertension in cardiac surgical patients
- Vasopressor selection in context of coronary perfusion pressure requirements
- Integration of transesophageal echocardiography findings with invasive hemodynamic parameters
- Documentation of pharmacologic reasoning for quality improvement and peer review







